enGene Holdings Inc. (ENGN)
(Delayed Data from NSDQ)
$7.19 USD
+0.33 (4.81%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $7.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for enGene Holdings Inc falls in the month of October.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -99.92 | 0.03 | 0.00 | NA | NA |
Depreciation/Amortization & Depletion | 0.18 | 0.24 | 0.00 | NA | NA |
Net Change from Assets/Liabilities | -0.52 | 1.08 | 0.00 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 75.52 | -1.86 | 0.00 | NA | NA |
Net Cash From Operating Activities | -24.74 | -0.76 | 0.00 | NA | NA |
Property & Equipment | -0.32 | -0.15 | 0.00 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | 0.00 | 0.00 | 0.00 | NA | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | NA | NA |
Net Cash from Investing Activities | -0.32 | -0.15 | 0.00 | NA | NA |
Uses of Funds
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 56.94 | 0.01 | 0.00 | NA | NA |
Issuance (Repayment) of Debt | -1.56 | 9.99 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | 34.82 | 18.40 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | -4.06 | -0.44 | 0.00 | NA | NA |
Net Cash from Financing Activities | 86.15 | 27.97 | 0.00 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | -0.81 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | 61.09 | -0.76 | 0.00 | NA | NA |
Cash at Beginning of Period | 20.43 | 1.07 | 0.00 | NA | NA |
Cash at End of Period | 81.52 | 0.31 | 0.00 | NA | NA |
Diluted Net EPS | -151.22 | NA | NA | NA | NA |
Fiscal Year End for enGene Holdings Inc falls in the month of October.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -39.84 | -25.70 | -10.71 | -99.92 | -3.85 |
Depreciation/Amortization & Depletion | 0.24 | 0.16 | 0.08 | 0.18 | 0.13 |
Net Change from Assets/Liabilities | 6.13 | 0.98 | 2.35 | -0.52 | 6.75 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.76 | 3.02 | 0.91 | 75.52 | -4.78 |
Net Cash From Operating Activities | -28.71 | -21.53 | -7.37 | -24.74 | -1.88 |
Property & Equipment | -0.69 | -0.69 | -0.51 | -0.32 | -0.18 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -2.53 |
Net Cash from Investing Activities | -0.69 | -0.69 | -0.51 | -0.32 | -2.53 |
Uses of Funds
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 206.09 | 206.03 | 0.00 | 56.94 | 0.02 |
Issuance (Repayment) of Debt | 13.06 | 13.06 | 13.06 | -1.56 | -0.38 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 34.82 | 4.18 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -13.58 | -13.58 | -1.06 | -4.06 | -2.33 |
Net Cash from Financing Activities | 205.56 | 205.51 | 12.00 | 86.15 | 4.18 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 176.16 | 183.29 | 4.13 | 61.09 | -0.23 |
Cash at Beginning of Period | 81.52 | 81.52 | 81.52 | 20.43 | 0.31 |
Cash at End of Period | 257.68 | 264.81 | 85.65 | 81.52 | 0.09 |
Diluted Net EPS | -0.32 | -0.38 | -0.46 | -150.98 | -0.05 |